A Novel Combination Oral Agent to Treat Acne Vulgaris

NCT01301586 · clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
60
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Nexgen Dermatologics, Inc.